GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Clinical trials for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS explained in plain language.
Never miss a new study
Get alerted when new GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS trials appear
Sign up with your email to follow new studies for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug may ease period problems in teens
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a GLP-1 drug can improve irregular periods in teenage girls with type 1 diabetes. Researchers will track period patterns in 50 girls aged 12-18 who have poor blood sugar control. The goal is to see if the drug helps make cycles more regular.
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Phase: PHASE1, PHASE2 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated May 26, 2026 07:48 UTC
-
Do weight-loss drugs make surgery riskier? new study investigates fasting times
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how GLP-1 receptor agonists (like Ozempic or Wegovy) affect stomach emptying in people scheduled for surgery. These drugs help with weight loss by slowing digestion, but standard fasting rules before surgery may not be enough to prevent food or liquid from ent…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Sponsor: Wael Saasouh, MD • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC